Related Experiment Videos
Pseudophakic cystoid maculopathy: a study of 50 cases
Ophthalmology
|September 1, 1981
Summary
Pseudophakic cystoid macular edema (PCME) affects 6.1% of patients after cataract surgery, particularly younger individuals. This condition, linked to inflammation, often recurs and may not resolve spontaneously, impacting visual acuity.
Area of Science:
- Ophthalmology
- Retinal Diseases
- Surgical Complications
Background:
- Cystoid macular edema (CME) is a known complication of cataract surgery.
- Pseudophakic maculopathy can be more severe than typical CME.
- Understanding PCME incidence and risk factors is crucial for patient management.
Purpose of the Study:
- To determine the incidence of pseudophakic cystoid macular edema (PCME) after cataract surgery.
- To identify clinical factors associated with PCME.
- To evaluate the efficacy and recurrence patterns of PCME.
Main Methods:
- Retrospective review of 50 cases of CME following intracapsular cataract extraction and intraocular lens implantation.
- Analysis of 821 consecutive cataract surgery cases.
- Clinical observation of patient demographics, inflammation, treatment response, and visual acuity outcomes.
Main Results:
- Overall PCME incidence was 6.1%, with a significantly higher rate (approx. 20%) in patients under 65.
- Chronic inflammation was identified as a cause of PCME.
- Systemic steroid therapy was effective in 80% of cases within 10 days.
- PCME demonstrated a high recurrence rate, often requiring maintenance steroid therapy.
- 44% of patients did not achieve better than 20/40 visual acuity.
Conclusions:
- PCME is a significant complication of cataract surgery, especially in younger patients.
- Chronic inflammation plays a key role in the development of PCME.
- PCME is frequently recurrent and can lead to persistent visual impairment, underscoring the need for vigilant management.